Anadys Pharmaceuticals, Inc. (ANDS) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	1.08M
Securities available-for-sale	18.08M
Prepaid expenses and other current assets	902K
Total current assets	20.07M
Property and equipment, net	107K
Total assets	20.17M
Accounts payable and accrued expenses	6.9M
Common stock warrant liability	460K
Deferred rent	14K
Total current liabilities	7.37M
Other long-term liabilities	1K
Commitments and contingencies	0
Preferred stock, $0.001 par value; 10,000,000 shares authorized at June 30, 2011 and December 31, 2010; no shares issued and outstanding at June 30, 2011 and December 31, 2010	0
Common stock, $0.001 par value; 90,000,000 shares authorized at June 30, 2011 and December 31, 2010; 57,176,285 and 57,141,223 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	57K
Additional paid-in capital	335.62M
Accumulated other comprehensive gain (loss)	12K
Accumulated deficit	-322.89M
Total stockholders' equity	12.8M
Total liabilities and stockholders' equity	20.17M

Entities mentioned with ANDS

View All Entities